Table 1.
Comparison of baseline data between the two groups.
| Relevant factors | O group (n = 43) | C group (n = 53) | t/χ2 | P |
|---|---|---|---|---|
| Average age (years) | 54.18 ± 8.61 | 54.73 ± 9.03 | 0.303 | >0.05 |
| BMI | 22.72 ± 0.45 | 22.56 ± 0.52 | 0.115 | >0.05 |
| Pathological typing | 0.487 | >0.05 | ||
| Squamous cell carcinoma | 35 (81.40) | 40 (75.47) | ||
| Adenocarcinoma | 8 (18.60) | 13 (24.53) | ||
| FLGO staging | 0.583 | >0.05 | ||
| I B3 period | 19 (44.19) | 26 (49.06) | ||
| II A period | 24 (55.81) | 27 (50.95) | ||
| HPV infection rate | 21 (48.83) | 20 (37.73) | 1.195 | >0.05 |
| Degree of differentiation | 1.917 | >0.05 | ||
| Low differentiation | 22 (51.16) | 20 (37.74) | ||
| Middle differentiation | 12 (27.91) | 21 (39.62) | ||
| Highly differentiated | 9 (20.93) | 11 (20.75) | ||
| Menopause | 0.527 | >0.05 | ||
| Yes | 27 (62.79) | 37 (69.81) | ||
| No | 16 (37.21) | 16 (30.19) |